BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32644030)

  • 1. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
    Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
    Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
    [No Abstract]   [Full Text] [Related]  

  • 2. Capacity to report on mortality attributable to chronic hepatitis B and C infections by Member States: An exercise to monitor progress towards viral hepatitis elimination.
    Duarte G; Williams CJ; Vasconcelos P; Nogueira P
    J Viral Hepat; 2018 Jul; 25(7):878-882. PubMed ID: 29479771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.
    Ou TY; Huy LD; Mayne J; Shih CL; Mai Xuan H; Thi Hong Nguyen N; Nguyen Hoai L; Thi My Bui L; Chang YM; Abdi AA; Hsu SC; Lin HJ; Huang CC
    J Infect Public Health; 2024 Jul; 17(7):102443. PubMed ID: 38838606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.
    Perz JF; Armstrong GL; Farrington LA; Hutin YJ; Bell BP
    J Hepatol; 2006 Oct; 45(4):529-38. PubMed ID: 16879891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic liver disease mortality attributable to hepatitis B and C in New Zealand.
    Weir RP; Brunton CR; Blakely TA
    J Gastroenterol Hepatol; 2002 May; 17(5):582-8. PubMed ID: 12084033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
    Duffell E; Cortez-Pinto H; Simonova M; Dalgard O; Dahl EH; de Martel C; Mozalevskis A; Buti M; Pavlova S; Hadzhilova T; Simões C; Katzarov K; Mardh O
    J Viral Hepat; 2021 Aug; 28(8):1177-1189. PubMed ID: 34003542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation effect of hepatitis B and C on mortality.
    Huang YT; Freeman JR; Yang HI; Liu J; Lee MH; Chen CJ
    Eur J Epidemiol; 2016 Jun; 31(6):625-33. PubMed ID: 26792787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
    Khan G; Hashim MJ
    Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
    GBD 2019 Europe Hepatitis B & C Collaborators
    Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital discharges of hepatocellular carcinoma and non-alcohol related cirrhosis in the EU/EEA and United Kingdom: a descriptive analysis of 2004-2015 data.
    Nakitanda AO; Duffell E
    Infect Dis (Lond); 2020 Nov; 52(11):816-827. PubMed ID: 32838640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India.
    Islami F; Dikshit R; Mallath MK; Jemal A
    Cancer Epidemiol; 2016 Feb; 40():79-86. PubMed ID: 26683034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
    Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
    J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
    Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
    HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
    Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
    Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma.
    Tong CY; Khan R; Beeching NJ; Tariq WU; Hart CA; Ahmad N; Malik IA
    Epidemiol Infect; 1996 Oct; 117(2):327-32. PubMed ID: 8870630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.